Van Eck Associates Corp Jazz Pharmaceuticals PLC Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Van Eck Associates Corp holds 60,211 shares of JAZZ stock, worth $7.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,211

Previous 54,054 11.39%

Holding current value

$7.4 Million

Previous $5.77 Million 15.98%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$100.57 - $116.37 $619,209 - $716,490	6,157 Added 11.39%	60,211 $6.69 Million
Q2 2024 Jul 31, 2024	BUY	$103.94 - $118.98 $245,402 - $280,911	2,361 Added 4.57%	54,054 $5.77 Million
Q1 2024 Apr 30, 2024	SELL	$115.19 - $132.77 $3.03 Million - $3.49 Million	-26,315 Reduced 33.73%	51,693 $6.22 Million
Q4 2023 Feb 05, 2024	SELL	$114.26 - $136.0 $858,549 - $1.02 Million	-7,514 Reduced 8.79%	78,008 $9.6 Million
Q3 2023 Nov 08, 2023	SELL	$122.0 - $145.31 $3.31 Million - $3.94 Million	-27,138 Reduced 24.09%	85,522 $11.1 Million
Q2 2023 Aug 03, 2023	BUY	$122.5 - $147.16 $5.75 Million - $6.9 Million	46,908 Added 71.34%	112,660 $14 Million
Q1 2023 May 03, 2023	SELL	$133.98 - $160.47 $6.07 Million - $7.26 Million	-45,271 Reduced 40.78%	65,752 $9.62 Million
Q4 2022 Feb 08, 2023	BUY	$129.72 - $159.85 $2.05 Million - $2.53 Million	15,825 Added 16.62%	111,023 $17.7 Million
Q3 2022 Oct 27, 2022	SELL	$126.59 - $161.18 $5.35 Million - $6.82 Million	-42,293 Reduced 30.76%	95,198 $12.7 Million
Q2 2022 Aug 03, 2022	BUY	$141.59 - $168.66 $8.89 Million - $10.6 Million	62,815 Added 84.12%	137,491 $21.5 Million
Q1 2022 May 10, 2022	BUY	$129.64 - $160.7 $129 - $160	1 Added 0.0%	74,676 $11.6 Million
Q4 2021 Jan 26, 2022	BUY	$119.87 - $145.67 $1.88 Million - $2.28 Million	15,650 Added 26.51%	74,675 $9.51 Million
Q3 2021 Nov 03, 2021	BUY	$128.64 - $184.79 $2.55 Million - $3.67 Million	19,836 Added 50.62%	59,025 $7.69 Million
Q2 2021 Aug 10, 2021	BUY	$160.2 - $186.42 $86,508 - $100,666	540 Added 1.4%	39,189 $6.96 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $3.12 Million - $3.6 Million	-20,768 Reduced 34.95%	38,649 $6.35 Million
Q4 2020 Feb 09, 2021	SELL	$140.71 - $165.05 $776,578 - $910,910	-5,519 Reduced 8.5%	59,417 $9.81 Million
Q3 2020 Nov 12, 2020	BUY	$105.46 - $144.13 $785,255 - $1.07 Million	7,446 Added 12.95%	64,936 $9.26 Million
Q2 2020 Aug 10, 2020	BUY	$95.68 - $121.88 $488,350 - $622,075	5,104 Added 9.74%	57,490 $6.34 Million
Q1 2020 May 12, 2020	BUY	$87.74 - $152.74 $755,529 - $1.32 Million	8,611 Added 19.67%	52,386 $5.23 Million
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $1.27 Million - $1.65 Million	10,761 Added 32.6%	43,775 $6.54 Million
Q3 2019 Nov 08, 2019	SELL	$125.18 - $143.24 $2.36 Million - $2.7 Million	-18,847 Reduced 36.34%	33,014 $4.23 Million
Q2 2019 Aug 07, 2019	SELL	$125.55 - $144.48 $31,513 - $36,264	-251 Reduced 0.48%	51,861 $7.39 Million
Q1 2019 May 13, 2019	SELL	$121.81 - $142.95 $3.36 Million - $3.94 Million	-27,559 Reduced 34.59%	52,112 $7.45 Million
Q4 2018 Feb 12, 2019	BUY	$115.94 - $166.74 $753,841 - $1.08 Million	6,502 Added 8.89%	79,671 $9.88 Million
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $237,328 - $266,160	1,474 Added 2.06%	73,169 $12.3 Million
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $857,201 - $1.07 Million	-5,858 Reduced 7.55%	71,695 $12.4 Million
Q1 2018 May 11, 2018	SELL	$135.59 - $157.16 $1.27 Million - $1.47 Million	-9,366 Reduced 10.78%	77,553 $11.7 Million
Q4 2017 Feb 12, 2018	BUY	$131.06 - $150.39 $486,101 - $557,796	3,709 Added 4.46%	86,919 $11.7 Million
Q3 2017 Nov 09, 2017	BUY	$142.62 - $155.6 $4.62 Million - $5.04 Million	32,360 Added 63.64%	83,210 $12.2 Million
Q2 2017 Aug 11, 2017	BUY	N/A	50,850	50,850 $7.91 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Jazz Pharmaceuticals PLC Transaction History